Evidence map›Paper›PMID 35626063›Full record

ArticleCancers2022

Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group.

Michael Leisch, Michael Pfeilstöcker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Christoph Tinchon, Bernd Hartmann, Andreas Petzer and 13 more

2 registry-linked trialsOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01595295 completednot on this map

Registry on Hypomethylating Agents in Myeloid Neoplasms, Including Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) and Acute Myeloid Leukemia (AML)

TypeobservationalSponsorArbeitsgemeinschaft medikamentoese TumortherapieRan2009 to 2021Enrolled1,500ConditionsChronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Acute Myeloid LeukemiaArmsnon interventional
NCT04438889 recruitingnot on this map

Austrian Myeloid Registry

Typeobservational_patient_registrySponsorArbeitsgemeinschaft medikamentoese TumortherapieRan2020 to 2030Enrolled3,000ConditionsMyeloid DiseasesArmsNon-interventional
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 1 country.

Michael Leisch3rd Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, 5020 Salzburg, Austria.
Michael PfeilstöckerAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Reinhard StauderAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.ORCID 0000-0002-8993-9561
Sonja HeiblAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.ORCID 0000-0001-8182-990X
Heinz SillAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.ORCID 0000-0003-0993-4371
Michael GirschikofskyAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Margarete Stampfl-MattersbergerAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Christoph TinchonAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Bernd HartmannAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Andreas PetzerAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Martin SchrederAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
David KieslAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.ORCID 0000-0001-7396-9494
Sonia ValletAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Alexander Egle3rd Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, 5020 Salzburg, Austria.
Thomas Melchardt3rd Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, 5020 Salzburg, Austria.
Gudrun PiringerAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Armin ZebischAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.ORCID 0000-0002-4861-7021
Sigrid Machherndl-SpandlAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Dominik WolfAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Felix KeilAustrian Group of Medical Tumor Therapy (AGMT) Study Group, 1140 Vienna, Austria.
Manuel DrostAssign Data Management and Biostatistics GmbH, 6020 Innsbruck, Austria.
Richard Greil3rd Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-4462-3694
Lisa Pleyer3rd Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, 5020 Salzburg, Austria.
Paracelsus Medical University · ATHanusch Hospital · ATInnsbruck Medical University · ATKlinikum Wels-Grieskirchen · ATKrankenhaus der Elisabethinen · ATMedical University of Graz · ATAGO Austria · ATAustrian Breast & Colorectal Cancer Study Group · ATDonauspital · ATKarl Landsteiner University of Health Sciences · ATKepler Universitätsklinikum · ATLandeskrankenhaus Feldkirch · ATLKH Hochsteiermark · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute myeloid leukemiaadverse eventsazacitidinechronic myelomonocytic leukemiamyelodysplastic syndromesprospective cohort studyreal-world evidencetoxicitytreatment

Identifiers

PMID35626063
PMCPMC9140081
OpenAlexW4280628680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.